€23.56
0.51% today
L&S, Jul 02, 07:19 pm CET
ISIN
BE0003818359
Symbol
GLPG
Sector
Industry

Galapagos Share price

€23.46
-2.12 8.29% 1M
-13.97 37.32% 6M
-13.53 36.58% YTD
-14.24 37.77% 1Y
-34.90 59.80% 3Y
-97.04 80.53% 5Y
+8.17 53.43% 10Y
Amsterdam, Closing price Tue, Jul 02 2024
+0.02 0.09%
ISIN
BE0003818359
Symbol
GLPG
Sector
Industry

Key metrics

Market capitalization €1.54b
Enterprise Value €-2.01b
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 3.81
EV/Sales (TTM) EV/Sales -3.69
P/S ratio (TTM) P/S ratio 2.84
P/B ratio (TTM) P/B ratio 0.53
Sales growth (TTM) Sales growth -5.75%
Turnover (TTM) Turnover €543.97m
EBIT (operating result TTM) EBIT €-208.88m
Free cash flow (TTM) Free cash flow €-525.95m
Cash position €3.56b
EPS (TTM) EPS €-2.33
P/E ratio expected negative
P/S ratio expected 4.71
EV/Sales expected negative
Show more

Is Galapagos a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,954 shares worldwide.

Galapagos Share analysis

Unlock Scores for Free

Analyst opinions

14 Analysts have issued a Galapagos forecast:

4x Buy
29%
10x Hold
71%

Analyst opinions

14 Analysts have issued a Galapagos forecast:

Buy
29%
Hold
71%

Financial data from Galapagos

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '24
+/-
%
544 544
1% 1%
100%
- Direct costs 39 39
46% 46%
7%
526 526
2% 2%
97%
- Selling and administrative expenses 269 269
26% 26%
49%
- Research and development costs 444 444
5% 5%
82%
- -
-
-
- Depreciation and amortization - -
-
-
EBIT (operating result) EBIT -209 -209
23% 23%
-38%
Net profit -153 -153
16% 16%
-28%

Figures in millions EUR.

Don't miss a thing! We will send you all news about the Galapagos share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Galapagos Share News

Neutral
GlobeNewsWire
18 days ago
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) at the annual European Hematology Association (EHA) 2024 Hybrid Congress. Galapagos' product candidate GLPG5101 is produce...
Neutral
GlobeNewsWire
about one month ago
Mechelen, Belgium and Philadelphia, PA, U.S. and Oxford, UK; 30 May 2024 22:01 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) and Adaptimmune Therapeutics plc (Nasdaq: ADAP) announced today that they have entered into a clinical collaboration agreement with an option to exclusively license Adaptimmune's next-generation TCR T-cell therapy (uza-cel) targe...
Neutral
GlobeNewsWire
about 2 months ago
Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right plans for the benefit of certain members of the personnel of the company and its subsidiaries.
More Galapagos News

Company profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Head office Belgium
CEO Paulus Stoffels
Employees 1,123
Founded 1999
Website www.glpg.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today